| View |
|
BR-603
|
Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, Adsorbed)
|
Gardasil
|
0.5mL (See Reverse Dosage)
|
Suspension for Injection IM
|
Prescription Drug (RX)
|
3mL USP/EP Type I glass vial with grey chlorobutyl stopper nad green plastic flip-off cap and Vaccine Vial Monitor (VVM30) [Box of 1's and 10's]
|
Vaccine
|
Merck Sharp & Dohme Corp.
|
United States of America
|
|
Merck Sharp & Dohme (I.A.) Corporation
|
|
Renewal
|
30 January 2020
|
19 October 2028
|
| View |
|
BR-615
|
Rotavirus Vaccine, Live
|
Rotateq
|
2mL
|
Solution For Oral Administration - Single Dose
|
Prescription Drug (RX)
|
2 mL single dose plastic dosing tube in individual foil pouch per box (Box of 1's, 10's, and 25's). Single Dose.
|
Vaccines
|
Merck Sharp & Dohme Corp
|
United States of America
|
`
|
Merck Sharp & Dohme (I.A.) LLC
|
|
Renewal
|
08 September 2024
|
02 August 2029
|
| View |
|
BR-616
|
Human Papillomavirus Vaccine [Types 16, 18]
(Recombinant, Adjuvanted, Adsorbed)
|
Cervarix
|
0.5 mL
|
Suspension For Injection (I.M.)
|
Prescription Drug (RX)
|
Single dose. Type I pre-filled glass syringe with butyl
rubber plunger stopper x 0.5 mL + Sterile needle 236 x 1" (Box of 1's)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
-
|
16 December 2021
|
07 September 2026
|
| View |
|
BR-619
|
Tetanus Toxoid Adsorbed
|
IMATET
|
40 IU/0.5 ML
|
SUSPENSION FOR INJECTION (IM)
|
Prescription Drug (Rx)
|
USP Type I Glass Ampoule (Box of 10's)
|
VACCINE
|
AMSON VACCINES & PHARMA (PVT.) LTD.
|
Pakistan
|
N/A
|
Sahar International Trading, Inc.
|
Sahar International Trading, Inc.
|
Renewal
|
05 August 2022
|
24 August 2027
|
| View |
|
BR-629
|
Purified Vero Cell Rabies Vaccine
|
Abhayrab
|
2.5 IU/0.5 mL
|
Freeze Dried Powder For Injection (I.M./I.D.)
|
Prescription Drug (RX)
|
Clear, colorless glass vial
|
Vaccine
|
Human Biologicals Institute (A Division of Indian Immunologicals Limited)
|
India
|
|
2 World Traders Inc
|
2 World Traders Inc
|
Automatic Renewal
|
22 December 2022
|
21 February 2028
|
| View |
|
BR-632
|
Epoetin alfa (Recombinant Human Erythropoietin)
|
Epotin
|
4000 IU/ mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (Rx)
|
1 mL glass vial (box of 10's)
|
Other Antianemic Preparations
|
Gulf Pharmaceuticals Industries (Julphar)
|
UAE
|
|
DéGa International Pharma Corp.
|
DéGa International Pharma Corp.
|
Automatic Renewal
|
10 August 2021
|
19 August 2026
|
| View |
|
BR-637
|
Epoetin Alfa
|
Epokine
|
4000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL Clear vial (Box of 10's)
|
Anti-anaemic Preparations
|
HK inno.N Corporation
|
Korea
|
|
Macropharma Corporation
|
Macropharma Corporation
|
Automatic Renewal
|
07 January 2022
|
20 October 2026
|
| View |
|
BR-638
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
50 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
-
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
18 September 2021
|
07 October 2026
|
| View |
|
BR-642
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
200 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
Erythropoiesis Stimulating Agent
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
23 September 2021
|
15 September 2026
|
| View |
|
BR-645
|
Epoetin Alfa
|
Epogen
|
4000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL prefilled glass syringe with red push rod and chlorobutyl rubber stopper in blister pack (Box of 1's)
|
Hematopoietic Growth Factors
|
Harbin Pharmaceutical Group Bioengineering Co.,
Ltd.
|
China
|
|
Endure Medical, Inc.
|
Endure Medical, Inc.
|
Renewal
|
20 August 2024
|
08 October 2029
|
| View |
|
BR-647
|
Methoxy Polyethylene Glycol-Epoetin Beta
|
Mircera
|
100 mcg/0.3 mL
|
Solution for Injection (I.V./S.C.)
|
Prescription Drug (Rx)
|
0.3 mL pre-filled glass syringe + 27 ½" needle per box of 1's. Single Dose.
|
Erythropoiesis Stimulating Agent
|
Roche Diagnostics GmbH
|
Germany
|
For: F. Hoffmann-La Roche Ltd.- Basel, Switzerland
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
Automatic Renewal
|
23 September 2021
|
15 September 2026
|
| View |
|
BR-651
|
Human Normal Immunoglobulin
|
Ig Vena
|
50mg/mL
|
Solution For Infusion (Iv)
|
Prescription Drug (RX)
|
Clear glass vial x 20mL, 100mL and 200mL (Box of 1's)
|
Immunoglobulin
|
Kedrion S.p.A
|
Italy
|
|
New Marketlink Pharmaceuticals Coporation
|
Metro Drug Inc.
|
Renewal
|
02 November 2023
|
07 November 2028
|
| View |
BR-653_PI_01.pdf
|
BR-653
|
Measles, Mumps, Rubella and Varicella Vaccine (Live,
Attenuated)
|
Priorix-Tetra
|
0.5 mL
|
Powder for Solution for Injection (S.C./1.M.)
|
Prescription Drug (RX)
|
One box contains Type I glass vial + 0.5 mL Type I pre filled glass syringe (Water for Injection as diluent) and two needles.
|
-
|
GlaxoSmithKline Biologicals SA (GSK Biologicals)
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Monitored Release (Variation)
|
11 July 2022
|
11 July 2027
|
| View |
|
BR-663
|
Tetanus Toxoid
|
Bio-TT
|
10 Lf/0.5 mL
|
Suspension for Injection (S.C./I.M.)
|
Prescription Drug (RX)
|
Single Use, Clear glass ampoule x 0.5 mL (Box of 10's)
|
Vaccines
|
P.T. Biofarma (Persero)
|
Indonesia
|
N/A
|
Maed Pharma Corporation
|
Maed Pharma Corporation
|
Renewal
|
11 December 2024
|
25 November 2028
|
| View |
|
BR-664
|
Cholera Vaccine (inactivated, oral)
|
OraVacs
|
Formulation Each capsule contains: Inactivated Whole Cell (WC)-5.0 x 10^10 of Vibrio cholerae 01 Inaba, classical biotype (heat inactivated)
Recombinant cholera toxin B subunit (ICTB)--1 mg (produced in V. cholerae 01 Inaba, classical biotype or El Tor biotype)
|
Enteric-Coated Capsule
|
Prescription Drug (RX)
|
Aluminum blister foil (Box of 3's)
|
Vaccines
|
Shanghai United Cell Biotechnology Co., Ltd.
|
China
|
|
ULIVaccines, Inc.
|
GB Distributors Inc.
|
Renewal
|
31 May 2024
|
26 November 2029
|
| View |
|
BR-669
|
Purified Rabies Vaccine (Vero Cell)
|
Speeda
|
2.5 IU
|
Freeze -Dried Powder for Injection (IM/ID)
|
Prescription Drug (RX)
|
5 Clear Glass Vial of Lyophilized Vaccine and 5 (0.5 mL diluent)
ampoules of Water for Injection in plastic tray per box
|
Vaccine
|
Liaoning Cheng Da Biotechnology Co., Ltd.
|
China
|
|
Pharma-Surrey International, Inc.
|
Pharma-Surrey International, Inc.
|
Renewal
|
28 December 2018
|
03 February 2029
|
| View |
|
BR-671
|
Human Normal Immunoglobulin(IGIV)
|
Gamma IV
|
50 mg/mL (2.5 g/50 mL)
|
Solution for IV Injection
|
Prescription Drug (RX)
|
50 mL USP Type I Glass Vial (Box of 1's)
|
Immuoglobulin
|
Bharat Serums and Vaccines Ltd.
|
India
|
|
BSV Bioscience Philippines, Inc.
|
Sandoval Distributors Inc.
|
Renewal
|
30 March 2021
|
10 February 2026
|
| View |
|
BR-673
|
Recombinant Human Thrombopoietin
|
Tpiao
|
15,000 IU/mL
|
Solution for Injection (S.C.)
|
Prescription Drug (Rx)
|
Single dose. Glass vial x 1mL (Box of 1's).
|
Colony-Stimulating Factors
|
Shenyang Sunshine Pharamceutical Co., Ltd.
|
China
|
N/A
|
Goodfellow Pharma Corporation
|
Goodfellow Pharma Corporation
|
Automatic Renewal
|
23 September 2022
|
23 September 2027
|
| View |
|
BR-674
|
Live Attenuated Rotavirus Vaccine
|
Rotarix
|
NLT 106.0 CCID 50/1.5 mL
|
Oral Suspension
|
Prescription Drug (RX)
|
Pre-filled glass syringe x 1.5 mL (Box of l's, 10's and
50's)
|
-
|
GlaxoSmithKline Biologicals S.A.
|
Belgium
|
|
GlaxoSmithKline Philippines, Inc.
|
|
Renewal
|
15 September 2022
|
13 August 2027
|
| View |
|
BR-676
|
Anti-Rabies Serum (Equine)
|
Equirab
|
200 IU/ mL (1,000 IU/ 5mL)
|
Solution for Injection (IM/SC)
|
Prescription Drug (Rx)
|
USP Type I Glass vial x 5mL (Box of 1's)
|
-
|
Bharat Serums and Vaccines Limited
|
India
|
|
NEW MARKETLINK PHARMACEUTICAL CORPORATION
|
NEW MARKETLINK PHARMACEUTICAL CORPORATION
|
-
|
30 March 2021
|
06 March 2026
|